Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis

References

• FranssenCFStegemanCAKallenbergCGAntiproteinase 3- and antimyeloperoxidase-associated vasculitisKidney Int20005762195220610844589
   PubMed Web of Science ®Google Scholar
• ComarmondCCacoubPGranulomatosis with polyangiitis (Wegener): clinical aspects and treatmentAutoimmun Rev201413111121112525149391
   PubMed Web of Science ®Google Scholar
• FinkielmanJDLeeASHummelAMWGET Research GroupANCA are detectable in nearly all patients with active severe Wegener’s granulomatosisAm J Med20071207).e9.e64317602941
   PubMed Web of Science ®Google Scholar
• GuillevinLDurand-GasselinBCevallosRMicroscopic polyangiitis: clinical and laboratory findings in eighty-five patientsArthritis Rheum199942342143010088763
   PubMed Web of Science ®Google Scholar
• JayneDRGaskinGRasmussenNEuropean Vasculitis Study GroupRandomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitisJ Am Soc Nephrol20071872180218817582159
   PubMed Web of Science ®Google Scholar
• FauciASHaynesBFKatzPWolffSMWegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 yearsAnn Intern Med198398176856336643
   PubMed Web of Science ®Google Scholar
• SeoPMinYIHolbrookJTWGET Research GroupDamage caused by Wegener’s granulomatosis and its treatment: prospective data from the Wegener’s granulomatosis etanercept trial (WGET)Arthritis Rheum20055272168217815986348
   PubMed Web of Science ®Google Scholar
• PopaERStegemanCABosNAKallenbergCGTervaertJWDifferential B- and T-cell activation in Wegener’s granulomatosisJ Allergy Clin Immunol19991035 pt 188589410329824
   PubMed Web of Science ®Google Scholar
• KrumbholzMSpecksUWickMKalledSLJenneDMeinlEBAFF is elevated in serum of patients with Wegener’s granulomatosisJ Autoimmun200525429830216242914
   PubMed Web of Science ®Google Scholar
• XinGChenMSuYXuLXZhaoMHLiKSSerum B-cell activating factor in myeloperoxiase-antineutrophil cytoplasmic antibodies-associated vasculitisAm J Med Sci20143481252924534784
   PubMed Web of Science ®Google Scholar
• JohnsonPGlennieMThe mechanisms of action of rituximab in the elimination of tumor cellsSemin Oncol2003301 Suppl 23812652458
   PubMed Web of Science ®Google Scholar
• JohnsonPWGlennieMJRituximab: mechanisms and applicationsBr J Cancer200185111619162311742477
   PubMed Web of Science ®Google Scholar
• RathEZwerinaJOpplBNell-DuxneunerVEfficacy and safety of rituximab in rheumatic diseasesWien Med Wochenschr20151651–2283525676699
   PubMedGoogle Scholar
• StoneJHMerkelPASpieraRRAVE-ITN Research GroupRituximab versus cyclophosphamide for ANCA-associated vasculitisN Engl J Med2010363322123220647199
   PubMed Web of Science ®Google Scholar
• JonesRBTervaertJWHauserTEuropean Vasculitis Study GroupRituximab versus cyclophosphamide in ANCA-associated renal vasculitisN Engl J Med2010363321122020647198
   PubMed Web of Science ®Google Scholar
• SpecksUFervenzaFCMcDonaldTJHoganMCResponse of Wegener’s granulomatosis to anti-CD20 chimeric monoclonal antibody therapyArthritis Rheum200144122836284011762944
   PubMed Web of Science ®Google Scholar
• KeoghKAWylamMEStoneJHSpecksUInduction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitisArthritis Rheum200552126226815641078
   PubMed Web of Science ®Google Scholar
• JonesRBFerraroAJChaudhryANA multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitisArthritis Rheum20096072156216819565480
   PubMed Web of Science ®Google Scholar
• KeoghKAYtterbergSRFervenzaFCCarlsonKASchroederDRSpecksURituximab for refractory Wegener’s granulomatosis: report of a prospective, open-label pilot trialAm J Respir Crit Care Med2006173218018716224107
   PubMed Web of Science ®Google Scholar
• FalkRJJennetteJCRituximab in ANCA-associated diseaseN Engl J Med2010363328528620647204
   PubMed Web of Science ®Google Scholar
• SpecksUMerkelPASeoPRAVE-ITN Research GroupEfficacy of remission-induction regimens for ANCA-associated vasculitisN Engl J Med2013369541742723902481
   PubMed Web of Science ®Google Scholar
• JonesRBFurutaSTervaertJWEuropean Vasculitis Society (EUVAS)Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trialAnn Rheum Dis20157461178118225739829
   PubMed Web of Science ®Google Scholar
• SmithRMJonesRBGuerryMJRituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitisArthritis Rheum201264113760376922729997
   PubMed Web of Science ®Google Scholar
• RheeEPLaliberteKANilesJLRituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated vasculitisClin J Am Soc Nephrol2010581394140020498238
   PubMed Web of Science ®Google Scholar
• Cartin-CebaRGolbinJMKeoghKARituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener’s): ten-year experience at a single centerArthritis Rheum201264113770377822730028
   PubMed Web of Science ®Google Scholar
• Roubaud-BaudronCPagnouxCMéaux-RuaultNFrench Vasculitis Study GroupRituximab maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitisJ Rheumatol201239112513022089465
   PubMed Web of Science ®Google Scholar
• PendergraftWF3rdCortazarFBWengerJLong-term maintenance therapy using rituximab-induced continuous B-cell depletion in patients with ANCA vasculitisClin J Am Soc Nephrol20149473674424626432
   PubMed Web of Science ®Google Scholar
• JayneDRasmussenNAndrassyKEuropean Vasculitis Study GroupA randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodiesN Engl J Med20033491364412840090
   PubMed Web of Science ®Google Scholar
• PagnouxCMahrAHamidouMAFrench Vasculitis Study GroupAzathioprine or methotrexate maintenance for ANCA-associated vasculitisN Engl J Med2008359262790280319109574
   PubMed Web of Science ®Google Scholar
• GuillevinLPagnouxCKarrasAFrench Vasculitis Study GroupRituximab versus azathioprine for maintenance in ANCA-associated vasculitisN Engl J Med2014371191771178025372085
   PubMed Web of Science ®Google Scholar
• TannaAPuseyCClinical trials. rituximab for maintenance of remission in AAVNat Rev Nephrol201511313113225599619
   PubMed Web of Science ®Google Scholar
• JayneDExtending the indications for rituximab in ANCA-associated vasculitisN Engl J Med2014371191839184025372093
   PubMed Web of Science ®Google Scholar
• LeeHAAlvaradoARovinBRituximab or azathioprine maintenance in ANCA-associated vasculitisN Engl J Med20153724385387
   Google Scholar
• HarperLSavageCOANCA-associated renal vasculitis at the end of the twentieth century – a disease of older patientsRheumatology (Oxford)200544449550115613403
   PubMed Web of Science ®Google Scholar
• TimlinHLeeSMMannoRLSeoPGeethaDRituximab for remission induction in elderly patients with ANCA-associated vasculitisSemin Arthritis Rheum Epub2015220
   Web of Science ®Google Scholar
• GeethaDEirinATrueKRenal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experienceTransplantation201191121370137521508899
   PubMed Web of Science ®Google Scholar
• GeraMGriffinMDSpecksULeungNStegallMDFervenzaFCRecurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupressionKidney Int200771121296130117410100
   PubMed Web of Science ®Google Scholar
• GeethaDSeoPSpecksUFervenzaFCSuccessful induction of remission with rituximab for relapse of ANCA-associated vasculitis post-kidney transplant: report of two casesAm J Transplant20077122821282517908274
   PubMed Web of Science ®Google Scholar
• MurakamiCManoharanPCarter-MonroeNGeethaDRituximab for remission induction in recurrent ANCA-associated glomerulonephritis postkidney transplantTranspl Int201326121225123124118474
   PubMed Web of Science ®Google Scholar
• HermleTGoestemeyerAKSwenyPBurnsASuccessful therapeutic use of rituximab in refractory Wegener’s granulomatosis after renal transplantationClin Nephrol200768532232618044265
   PubMed Web of Science ®Google Scholar
• PendergraftWF3rdMcGrathMMMurphyAPFetal outcomes after rituximab exposure in women with autoimmune vasculitisAnn Rheum Dis201372122051205323864238
   PubMed Web of Science ®Google Scholar
• OstensenMForgerFTreatment with biologics of pregnant patients with rheumatic diseasesCurr Opin Rheumatol201123329329821346578
   PubMed Web of Science ®Google Scholar
• KlinkDTvan ElburgRMSchreursMWvan WellGTRituximab administration in third trimester of pregnancy suppresses neonatal B-cell developmentClin Dev Immunol2008200827136318596903
   PubMedGoogle Scholar
• ChakravartyEFMurrayERKelmanAFarmerPPregnancy outcomes after maternal exposure to rituximabBlood201111751499150621098742
   PubMed Web of Science ®Google Scholar
• GeethaDKallenbergCStoneJHCurrent therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximabJ Nephrol2015281172725185728
   PubMed Web of Science ®Google Scholar
• ClainJMCartin-CebaRFervenzaFCSpecksUExperience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitisTher Adv Musculoskelet Dis201462587424688606
   PubMedGoogle Scholar
• JastiSCoyleTGentileTRosalesLPoieszBRituximab as an adjunct to plasma exchange in TTP: a report of 12 cases and review of literatureJ Clin Apher200823515115618712712
   PubMed Web of Science ®Google Scholar
• GuerryMJBroganPBruceINRecommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitisRheumatology (Oxford)201251463464321613248
   PubMed Web of Science ®Google Scholar
• TaylorSRSalamaADJoshiLPuseyCDLightmanSLRituximab is effective in the treatment of refractory ophthalmic Wegener’s granulomatosisArthritis Rheum20096051540154719404964
   PubMed Web of Science ®Google Scholar
• MansfieldNHamourSHabibAMProlonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitisNephrol Dial Transplant201126103280328621414973
   PubMed Web of Science ®Google Scholar
• Turner-StokesTSandhuEPepperRJInduction treatment of ANCA-associated vasculitis with a single dose of rituximabRheumatology (Oxford)20145381395140324609057
   PubMed Web of Science ®Google Scholar
• EvensAMJovanovicBDSuYCRituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reportsAnn Oncol20112251170118021115603
   PubMed Web of Science ®Google Scholar
• WesthoffTHJochimsenFSchmittelAFatal hepatitis B virus reactivation by an escape mutant following rituximab therapyBlood20031025193012930732
   PubMed Web of Science ®Google Scholar
• SarrecchiaCCappelliAAielloPHBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAbJ Infect Chemother200511418919116133710
   PubMedGoogle Scholar
• PerceauGDirisNEstinesODerancourtCLevySBernardPLate lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphomaBr J Dermatol200615551053105617034541
   PubMed Web of Science ®Google Scholar
• CooperNArnoldDMThe effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseasesBr J Haematol2010149131320151975
   PubMed Web of Science ®Google Scholar
• HuangYHHsiaoLTHongYCRandomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis BJ Clin Oncol201331222765277223775967
   PubMed Web of Science ®Google Scholar
• HuangHLiXZhuJEntecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trialJAMA2014312232521253025514302
   PubMed Web of Science ®Google Scholar
• CasuloCMaraguliaJZelenetzADIncidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infectionsClin Lymphoma Myeloma Leuk201313210611123276889
   PubMed Web of Science ®Google Scholar
• BesadaERoutine pneumocystis pneumonia prophylaxis in patients treated with rituximab?Chest2013144135936023880691
   PubMed Web of Science ®Google Scholar
• Martin-GarridoICarmonaEMSpecksULimperAHPneumocystis pneumonia in patients treated with rituximabChest2013144125826523258406
   PubMed Web of Science ®Google Scholar
• GreenHPaulMVidalLLeiboviciLProphylaxis of pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trialsMayo Clin Proc20078291052105917803871
   PubMed Web of Science ®Google Scholar